Malignancies after hematopoietic stem cell transplantation: many questions, some answers.

ALTHOUGH MANY ASPECTS of the development of malignant tumors are still incompletely understood, conditions have been identified under which malignancies develop at a higher frequency than in the population at large.[1-3][1] These include, for example, actinic exposure of the skin and the mutagenic

[1]  K. Pollok,et al.  Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes. , 1997, Transplantation.

[2]  C. Bordignon,et al.  HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. , 1997, Science.

[3]  A. Pileri,et al.  High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. , 1997, The New England journal of medicine.

[4]  K. Cornetta,et al.  Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. , 1997, American journal of clinical pathology.

[5]  R. Hoover,et al.  Solid cancers after bone marrow transplantation. , 1997, The New England journal of medicine.

[6]  K. Pollok,et al.  Post-transplant EBV induced lymphoproliferative disorders. , 1997, Leukemia & lymphoma.

[7]  P. Gaulard,et al.  Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  B. Barlogie,et al.  Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma , 1996, British journal of haematology.

[9]  J. Manivel,et al.  Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation. , 1996, Blood.

[10]  J. Radich.  Detection of minimal residual disease in acute and chronic leukemias , 1996, Current opinion in hematology.

[11]  Malcolm K. Brenner,et al.  Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes , 1996, Nature Medicine.

[12]  L. Robison,et al.  Malignant neoplasms following bone marrow transplantation. , 1996, Blood.

[13]  L. Kalish,et al.  Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. , 1996, Blood.

[14]  D. Linch,et al.  Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high‐dose chemotherapy and autologous bone marrow transplantation using X‐chromosome inactivation patterns , 1996, British journal of haematology.

[15]  R. Larson,et al.  Therapy-related myeloid leukemia. , 2008, Seminars in oncology.

[16]  S. Hancock,et al.  Second cancers after Hodgkin's disease in childhood. , 1996, The New England journal of medicine.

[17]  G. Heller,et al.  The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. , 1996, Blood.

[18]  M. Ladanyi,et al.  Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV- induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice [published erratum appears in J Exp Med 1996 Sep 1;184(3):1199] , 1996, The Journal of experimental medicine.

[19]  M. Stovall,et al.  Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Niland,et al.  Myelodysplasia and acute myeloid leukemia occurring after autologous bone marrow transplantation for lymphoma. , 1996, Leukemia & lymphoma.

[21]  M. Mielcarek,et al.  CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. , 1996, Blood.

[22]  K. Lucas,et al.  Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants. , 1996, Important advances in oncology.

[23]  G. Socié.  Secondary malignancies , 1996, Current opinion in hematology.

[24]  E. Jaffe,et al.  Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas. , 1996, Blood.

[25]  H. Deeg,et al.  Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. , 1996, Blood.

[26]  A. Hagenbeek,et al.  Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. , 1995, The New England journal of medicine.

[27]  C. Niemeyer,et al.  EBV‐associated lymphoproliferative syndrome with a distinct 69 base‐pair deletion in the LMP‐1 oncogene , 1995, British journal of haematology.

[28]  E. Cesarman,et al.  Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. , 1995, The American journal of pathology.

[29]  R. Fisher,et al.  Aggressive treatment for postcardiac transplant lymphoproliferation. , 1995, Blood.

[30]  G. Socié,et al.  Malignant diseases after bone marrow transplantation: the case for tumor banking and continued reporting to registries. EBMT Late-Effects Working Party. , 1995, Bone marrow transplantation.

[31]  M. Ho.  Risk factors and pathogenesis of posttransplant lymphoproliferative disorders. , 1995, Transplantation proceedings.

[32]  G. Storch,et al.  EPSTEIN‐BARR VIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES OF PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE , 1995, Transplantation.

[33]  R. Loertscher,et al.  A solitary plasmacytoma of donor origin arising 14 years after kidney allotransplantation , 1995, British journal of haematology.

[34]  J. Arends,et al.  Large‐cell anaplastic non‐Hodgkin's lymphoma originating in donor cells after allogenic bone marrow transplantation , 1995, British journal of haematology.

[35]  G. Jackson,et al.  Low frequency of myelodysplasia after autologous bone marrow transplantation , 1995, The Lancet.

[36]  A. Fischer,et al.  Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  J. Bennett.  Secondary acute myeloid leukemia. , 1995, Leukemia research.

[38]  L. Kumar.  Secondary leukaemia after autologous bone marrow transplantation , 1995, The Lancet.

[39]  R. Gascoyne,et al.  Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. , 1995, Bone marrow transplantation.

[40]  E. Blume.  Secondary leukemias receive increased attention. , 1995, Journal of the National Cancer Institute.

[41]  Yi Fang Liu,et al.  Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. , 1995, Blood.

[42]  E. Cesarman,et al.  Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders , 1995 .

[43]  R. Krance,et al.  Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.

[44]  J. Magaud,et al.  Post‐transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours , 1995, British journal of haematology.

[45]  R. Krance,et al.  Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative disease , 1995, British journal of haematology.

[46]  S. Hanauer,et al.  Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer. , 1995, Bone marrow transplantation.

[47]  E. Cesarman,et al.  Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. , 1995, Blood.

[48]  W. Chan,et al.  Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  A. Rohatiner.  Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  D. Neuberg,et al.  Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  J. Tanner,et al.  Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease. , 1994, Blood.

[52]  A. Hagenbeek,et al.  Risk of leukemia following treatment for non-Hodgkin's lymphoma. , 1994, Journal of the National Cancer Institute.

[53]  H. Atkins,et al.  Secondary malignancies after bone marrow transplantation in adults. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  N. Brousse,et al.  Donor B cell lymphoma of the brain after allogeneic bone marrow transplantation for acute myeloid leukemia. , 1994, Bone marrow transplantation.

[55]  H. Cen,et al.  EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease. , 1994, Leukemia & lymphoma.

[56]  J. Niland,et al.  Clonal Karyotypic Hematopoietic Cell Abnormalities Occurring After Autologous Bone Marrow Transplantation for Hodgkin's Disease and Non-Hodgkin's Lymphoma , 1994 .

[57]  S. Riddler,et al.  Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. , 1994, Blood.

[58]  D. Dunn,et al.  Clinical characteristics of post-transplant lymphoproliferative disorders. , 1994, The American journal of medicine.

[59]  G. Klein.  Epstein-Barr virus strategy in normal and neoplastic B cells , 1994, Cell.

[60]  H. Doornewaard,et al.  Posttransplant t‐cell lymphoma. Report of three cases and a review of the literature , 1994, Cancer.

[61]  J. Neglia,et al.  Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. , 1994, Blood.

[62]  R. Stone.  Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress. , 1994, Blood.

[63]  M. Forveille,et al.  Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice. , 1994, Journal of immunology.

[64]  H. Deeg,et al.  Secondary malignancies after marrow transplantation for leukemia or aplastic anemia. , 1994, Transplantation.

[65]  C. Alfieri,et al.  Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. , 1994, Blood.

[66]  M. Ladanyi,et al.  Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. , 1994, The New England journal of medicine.

[67]  J. Lieberman,et al.  Using T cells to treat B-cell cancers. , 1994, The New England journal of medicine.

[68]  D. O’Briain,et al.  Localized, late‐onset, high‐grade lymphoma following bone marrow transplantation: response to combination chemotherapy , 1994, British journal of haematology.

[69]  S. Brunet,et al.  Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation , 1993, American journal of hematology.

[70]  C. Alfieri,et al.  Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease , 1994 .

[71]  M. Henry-Amar,et al.  Malignant diseases after allogeneic bone marrow transplantation: an updated overview. , 1994, Nouvelle revue francaise d'hematologie.

[72]  Stephen,et al.  Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. , 1994, Blood.

[73]  K. Maclennan,et al.  Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy. , 1993, British Journal of Cancer.

[74]  B. Leber,et al.  B‐cell lymphoma of recipient origin 9 years after allogeneic bone marrow transplantation for T‐cell acute lymphoblastic leukaemia , 1993, British journal of haematology.

[75]  Deeg Hj,et al.  Risk factors for the development of secondary malignancies after marrow transplantation. , 1993 .

[76]  J. Sklar,et al.  Molecular genetic analysis of post-transplant lymphoproliferative disorders. , 1993, Hematology/Oncology Clinics of North America.

[77]  S. Nishikawa,et al.  Sequential analysis of hematopoietic reconstitution achieved by transplantation of hematopoietic stem cells. , 1993, Blood.

[78]  S. Burrows,et al.  Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination. , 1993, Journal of immunology.

[79]  J. Hansen,et al.  Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. , 1993, The New England journal of medicine.

[80]  H. Cen,et al.  Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. , 1993, Blood.

[81]  C. Gisselbrecht,et al.  Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphomas. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  A. Fischer,et al.  Therapy for transplant-related lymphoproliferative diseases. , 1993, Hematology/oncology clinics of North America.

[83]  H. Deeg,et al.  Risk factors for the development of secondary malignancies after marrow transplantation. , 1993, Hematology/oncology clinics of North America.

[84]  T. Starzl,et al.  Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. , 1992, The New England journal of medicine.

[85]  A. Fischer,et al.  Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. , 1992, The Journal of clinical investigation.

[86]  A. Fischer,et al.  TREATMENT OF CENTRAL NERVOUS SYSTEM B LYMPHOPROLIFERATIVE SYNDROME BY LOCAL INFUSION OF A B CELL‐SPECIFIC MONOCLONAL ANTIBODY , 1992, Transplantation.

[87]  P. Ljungman,et al.  MALIGNANT DISEASES AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION: THE CASE FOR ASSESSMENT OF RISK FACTORS , 1992, British journal of haematology.

[88]  H. Müller-Hermelink,et al.  Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients , 1991, Virchows Archiv. B, Cell pathology including molecular pathology.

[89]  T. Donlon,et al.  Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  A. Fischer,et al.  Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. , 1991, The New England journal of medicine.

[91]  J. Cohen.  Epstein‐Barr Virus Lymphoproliferative Disease Associated with Acquired Immunodeficiency , 1991, Medicine.

[92]  R. Fisher,et al.  Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. , 1990, The New England journal of medicine.

[93]  R. Hackman,et al.  Secondary T-cell lymphoproliferation after marrow transplantation. , 1990, American journal of clinical pathology.

[94]  F. Appelbaum,et al.  Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. , 1990, The New England journal of medicine.

[95]  J. Dubé,et al.  Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[96]  R. Shapiro.  Epstein-Barr virus-associated B-cell lymphoproliferative disorders in immunodeficiency: meeting the challenge. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  E. Kieff,et al.  Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. , 1989, The New England journal of medicine.

[98]  H. Deeg,et al.  Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. , 1989, The New England journal of medicine.

[99]  J. Tobacman,et al.  Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone. , 1989, Transplantation proceedings.

[100]  J. Tobacman,et al.  INCREASED FREQUENCY OF POSTTRANSPLANT LYMPHOMAS IN PATIENTS TREATED WITH CYCLOSPORINE, AZATHIOPRINE, AND PREDNISONE , 1989, Transplantation.

[101]  M. Trigg,et al.  Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[102]  M. Zutter,et al.  Epstein-Barr virus lymphoproliferation after bone marrow transplantation. , 1988, Blood.

[103]  A. Craft,et al.  Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. , 1988, The New England journal of medicine.

[104]  B. Burke,et al.  Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. , 1988, Blood.

[105]  G. Hale,et al.  T CELL DEPLETION WITH CAMPATH‐1 IN ALLOGENEIC BONE MARROW TRANSPLANTATION , 1988, Transplantation.

[106]  C. Griscelli,et al.  Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation. , 1988, Annals of internal medicine.

[107]  J. Sklar,et al.  Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. , 1988, Blood.

[108]  F. Greco,et al.  Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  D M Green,et al.  Bone sarcomas linked to radiotherapy and chemotherapy in children. , 1987, The New England journal of medicine.

[110]  D. Crawford,et al.  Epstein-Barr virus infection and immunity in bone marrow transplant recipients. , 1986, Transplantation.

[111]  G. Tricot,et al.  [Immunoblastic lymphoma after bone marrow graft. Apropos of a case treated by OKT3 monoclonal antibodies for an acute graft versus host reaction]. , 1986, Annales de pathologie.

[112]  J. Sullivan,et al.  Lymphoma of host origin in a marrow transplant recipient in remission of acute myeloid leukemia and receiving cyclosporin A , 1985, American journal of hematology.

[113]  S. Forman,et al.  Epstein-Barr-virus induced lymphoproliferation. Implications for antiviral chemotherapy. , 1984, The New England journal of medicine.

[114]  H. Deeg,et al.  Secondary malignancies after marrow transplantation. , 1984, Experimental hematology.

[115]  H. Deeg,et al.  Increased incidence of malignant tumors in dogs after total body irradiation and marrow transplantation. , 1983, International journal of radiation oncology, biology, physics.

[116]  J. Stephenson,et al.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.

[117]  R. Hackman,et al.  A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. , 1982, Blood.

[118]  D. L. Swain,et al.  Hiroshima and Nagasaki. The Physical, Medical, and Social Effects of the Atomic Bombings. , 1982 .

[119]  E. Thomas,et al.  The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. , 1982, Leukemia research.

[120]  G. Silver.  Hiroshima and Nagasaki: The Physical, Medical and Social Effects of the Atomic Bombings by Tha Committee for tha Compilation of Materials on Damage Caused by the Atomic Bombs in Hiroshima and Nagasaki (Basic Books; xiv + 706 pp.; $37.50) , 1981 .

[121]  J. Boice.  Cancer following medical irradiation , 1981, Cancer.

[122]  Andrew J. Pierre.  Hiroshima and Nagasaki: The Physical, Medical, and Social Effects of the Atomic Bombings , 1981 .

[123]  M. V. van Zwieten,et al.  Tumour induction in Rhesus monkeys after total body irradiation with X-rays and fission neutrons. , 1981, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[124]  B. Netzel,et al.  Dose rate and dose fractionation studies in total body irradiation of dogs. , 1979, Pathologie-biologie.

[125]  C. Taylor,et al.  Immunoblastic sarcoma in donor cells after bone-marrow transplantation. , 1979, The New England journal of medicine.

[126]  H. Gleichmann,et al.  Lymphomagenesis and autoimmunization caused by reactions of T-lymphocytes to incompatible structures of the major histocompatibility complex: a concept of pathogenesis. , 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[127]  R. Mole.  Late effects of radiation: carcinogenesis. , 1973, British Medical Bulletin.

[128]  E. Cornelius,et al.  RAPID VIRAL INDUCTION OF MURINE LYMPHOMAS IN THE GRAFT-VERSUS-HOST REACTION , 1972, The Journal of experimental medicine.

[129]  E. Cornelius.  Rapid Immunological Induction of Murine Lymphomas: Evidence for a Viral Etiology , 1972, Science.

[130]  R. Schwartz,et al.  Immunoregulation, oncogenic viruses, and malignant lymphomas. , 1972, Lancet.

[131]  P. Neiman,et al.  Leukaemic transformation of engrafted human cells in vivo. , 1971, Lancet.

[132]  P. Neiman,et al.  Leukaemic transformation of engrafted human marrow cells in vivo. , 1971, Lancet.

[133]  G. Martin,et al.  Parasexual Cycle in Cultivated Human Somatic Cells , 1969, Science.

[134]  R. Schwartz,et al.  Malignant Lymphomas Following Allogenic Disease: Transition from an Immunological to a Neoplastic Disorder , 1965, Science.

[135]  Anonymous.  REVIEW. , 1911 .